Executive Council

Dr. Tufail Syed, CEO – Q Pharm, Australia;  President Clinical Research Society

Dr. Syed is an experienced clinical research and medical affairs professional with a proven track record of excellence in building and managing teams, provide leadership, change management, management of outsourced partners, and complex project delivery, gained in both pharmaceutical as well as CRO engagements. Having been involved in a number of clinical development programs Dr. Syed brings with him more than 12 years of valuable experience in basic research and the area of new drug and device development. Some key positions previously held by him include Sr. Clinical Research Physician and Medical Advisor at Eli Lilly & Company, and Managing Director at Medpace India. He has also served as the Sr. Director – Laboratory Operations in Covance, based in Singapore. Currently he is the Chief Executive Officer for Q Pharm, based in Australia.


Dr. Shailesh Chavan   Senior Director, Clinical Development, Biotest Pharmaceuticals Corporation , Florida, USA

Dr. Shailesh Chavan is presently serving as the Senior Director, Clinical Development, Drug Safety & Medical Affairs at Biotest Pharmaceuticals Corporation (BPC) based in West Palm Beach, Florida, USA. In the past he has served as the Director, Clinical Development and Operations for ClinTec International. Dr. Chavan has significant experience in leading Clinical Research Departments, Clinical Operations and Pharmacovigilance activities in the conduct of clinical trials for all phases of development. He is heading large teams of Clinical Project Managers, MDs, and PhDs in managing clinical trials. Dr. Chavan is a qualified physician from the Seth G.S. Medical College in Mumbai and holds an MD in Internal Medicine from Bombay Hospital Institute of Medical Sciences.


Dr. Ross Horsburgh VP & Head of Clinical Development Asia Pacific , Nycomed, Singapore

Dr Horsburgh is a New Zealand trained physician who has worked in Asia for 15 years in both R&D and commercial roles for two large MNC pharmaceutical companies. During this time he built clinical development organisations to deliver global clinical trials across 14 markets. During his 5 years in Beijing and 10 years in Singapore, he has led teams working on projects in all the major therapy areas. Dr Horsburgh has a strong interest in talent development and regulatory matters associated with global drug development. Over recent years he has led projects focused on increasing market access for new drugs using innovative models for getting new drugs to patients faster and more efficiently. These interests led him to join the USA-based multinational CRO Kendle International, Inc. in January 2008 as VP Asia Pacific region, based in Singapore and then Nycomed as VP & Head of Clinical Development Asia Pacific in 2010.


Dr. Calin Popa, Director, Clinical Training and Development at Advanced Clinical Research Services, Montreol, Canada

Dr. Popa is  the Director, Clinical Training and Development at Advanced Clinical Research Services, Montreol, Canada. He is also a Senior Clinical Research Consultant. Dr. Popa has a MD degree and is CCRA (ACRP), having a solid background in business, clinical research and medical care. He is qualified to monitor, lead and direct clinical trials internationally. During his 10+ years in this industry, he has managed clinical trial budgets , negotiated numerous contracts with both large companies and investigators and has successfully worked on phase I – IV trials in a variety of disease indications such as Oncology, Cardiology, CNS, Infectious Disease, Immunology and Dermatology, just to name a few. During his previous professional assignments, he has worked for Kendle, Eli Lilly, Medfocus, INC Research and Amgen. He has proven working knowledge of ICH GCP and FDA / TPD / EMEIA regulations, proven ability to cope both with scientific and organizational aspects of drugs and medical devices studies, high ability to understand complex medical concepts and to cope both with scientific and organizational aspects. His is multilingual, fluent in French, English, German and Romanian) Although he lives in Canada, he is an EU citizen and a Nexus member, which makes traveling for him very easy around the world.

Dr. Petr Potuznik , Medical Director at Neox , Prague, Europe

Dr. Petr Potuznik is currently the Medical Director at Neox Europe. He is a trained physician from the Univerzita Karlova v Praze and holds a specialization in Internal Medicine from the same University. Petr is also certified for teaching Medical Informatics in EU from the Erasmus Universiteit Rotterdam.

Petr started his career as a CRA with Parexel in the Czech Republic and then worked as a team leader with Quintiles. Eventually he founded ‘MONAX’ a CRO in 2000 which was later acquired by Medpace in 2007. He worked with Medpace as General Manager & Medical (Scientific) Monitor till 2010 before joining Neox.

Petr has over the years been involved in a variety of consultancy and medical review services in clinical research studies from Phase I to IV across the globe. He has tremendous experience in independent review of study protocols, identifying obstacles and difficulties in clinical studies, providing expert opinion in therapeutic areas such as CVS and DM, feasibility surveys, medical review of data etc.



Dr. Nirvana Pillay , Managing Director at Xcell Bioconsulting, Cape Town Area, South Africa

Nirvana holds a PhD degree in Neuroscience from the University of Cape Town (UCT). Part of her doctoral training was done at ETH in Zurich, Switzerland. She obtained a BSc degree in Psychology and Genetics from the University of Natal, before obtaining  BSc(Med) Honours degree in Human genetics at UCT. She has several first-author publications in peer-reviewed international medical journals, one of which is published in the Expert Opinion on Emerging Drugs. She has also attended international conferences in which she had given oral presentations and seminars. Nirvana has done courses in Project Management in 2006 (UCT), Bio-entrepreneurship in 2007 (Karolinska Institute) and Good Clinical Practice in 2008 (University of Stellenbosch).

She had worked as a postdoctoral scientist on Anxiety disorders in the Department of Psychiatry and Mental Health at UCT. She then continued postdoctoral studies on Prions at the neuroscience department at Karolinska Institute in Stockholm, Sweden for which she was funded by the World Health Organisation in 2007. Nirvana then worked in the biotechnology field as Senior scientist and Project manager in tuberculosis diagnostic research. She had managed projects and lead a group of scientists in diagnostic testing and clinical research in tuberculosis.

She is a member of the International Brain Research Organisation (IBRO), South African Neuroscience Society (SANS) and New York Academy of Sciences (NYAS).Nirvana has recently completed her MBA at the Management College of Southern Africa. She is Managing Director at XCell Bioconsulting, the leading bioconsulting firm in Southern Africa,  and is pursuing her interest in providing high quality services in the  biopharmaceutical industry.


Dr. Mufti Suhail Sayeed, Vice President, Venus Medicine Research Centre, Venus Remedies, India

Dr. Mufti is a trained physician and holds a Masters degree in Translational Medicine from the University of Edinburgh. He also holds a Masters degree in Business Administration and is currently the Vice President at Venus Medicine Research Centre (VMRC), Venus Remedies Ltd.

He is experienced in conducting Phase I to Phase IV studies in various therapeutic areas such as CVS, endocrinology, metabolics, oncology and dermatology. Currently he is involved in translational research in the area of infectious diseases, cardiovascular diseases, cancer diagnostics and therapeutics, immunology and lung diseases. Dr. Mufti has previously served as Country Manager based at Riyadh, Saudi Arabia for Clinart International/MECRO, a leading contract research organization in the Middle East.


Dr. Ambrish Srivastava, Head for Clinical Research, Torrent Research Center, Torrent Pharmaceuticals, India

Dr. Ambrish Srivastava is Head for Clinical Research at Torrent Research Center, Torrent Pharmaceuticals, Ahmedabad. A very well known figure on the Indian clinical research landscape, Dr. Srivastava has more than 10 years of experience in pharmaceutical industries with high academic acumen. He has worked as therapeutic area physician in the areas of oncology, cardiology, infectious disease management, diabetes, rheumatology, gastroenterology, nephrology, neurology and psychiatry. He has extensive experience in clinical research, promotional strategies and drug safety.

In his previous assignments, Dr. Srivastava has worked with Eli Lilly as Clinical Research Physician, and  Dr. Reddy’s Laboratories as Director for Medical Affairs. He has also held senior positions at Zydus Cadilla and Intas Biopharmaceuticals. Dr. Srivastava is the recipient of many awards which include Vishisht Chikitsa Medal by Governor of Andhra Pradesh and Rashtriya Ratan by Governor of Gujarat.

Dr. Srivastava is an avid speaker at various national and international conferences and participates keenly with the clinical research fraternity in India and abroad.


Dr. Sarwat Faisal, Medical Director, Roche Pakistan Ltd., Pakistan

Dr. Sarwat Faisal is a trained physician from the Karachi University and is currently the Medical Director, Roche Pakistan Ltd., Pakistan. Previously she was the Head of Medical Affairs at Merck KGaA, Pakistan. She has more than 13 years of industry experience and has worked for some leading pharmaceutical companies. She started her career as a Medical Manager with Sante (Private) Ltd., and subsequently gained more experience at Eli Lilly & Company, and eventually Merck KGaA, Pakistan.

Dr. Sarwat is trained in ICH-GCP and highly experienced in areas such as clinical research, pharmacovigilance, medical affairs and strategic planning. Diabetes, Cardiology and Oncology are her major therapeutic areas of expertise.



Dr. Yousef Alomi, Head of Regional Drug and Poisoning Information Center, King Saud Medical City, Saudi Arabia

Dr Yousef AlomiDr. Alomi is a product of King Saud University confirmed with the degree of Bachelor of Pharmaceutical Sciences in the year 1992. After six-years of higher study, he earned his Master of Clinical Pharmacy from the same university. He is an affiliated clinical instructor of Purdue University in the USA.

Dr. Alomi is an assistant professor at King Saud University, Saudi Arabia. In the year 2005 he obtained Board Certification of Pharmacotherapy Specialist (BCPS). In the year 2008, he obtained his diploma in business administration from American University in Egypt and in 2009, he obtained a Board Certification of Nutrition Support Pharmacy (BCNSP). He became a member of advisory board of the Arab  Pharmaceutical Journal in 2010.


Dr. Seema Rajsingh, Head of Pharmacovigilance, Biocon Ltd., India 

Dr Seema Rajsingh is a trained medical doctor with 15 years of professional experience.  She did her MBBS from Lady Hardinge Medical College, New Delhi in 1995.  Subsequently,  after a few years of medical work experience she did her MD in Pharmacology from Delhi University in 2001.  She was honored with the Professional Member of Institute of Clinical Research (MICR), London, UK in 2006.  She is also a member of the Project Management Institute (PMI), USA.

Before joining Biocon, she was working as Associate Director, Pharmacovigilance with Quintiles Transnational at their CoE for Pharmacovigilance in Bangalore, India for Johnson and Johnson (JnJ) and was involved in scaling up the PV operations from a small team of 30 to 165 in 7 months. Prior to that she was with Accenture, helping them in setting up their Pharmacovigilance practice at Chennai for the Bristol Myers Squibb deal.


Dr. Sanjeev Miglani, COO & Scientific Director, CIDP Biotech, India

Dr. Sanjeev Miglani completed his MD Internal Medicine from Dr. RML Hospital, Delhi University and MBBS from Maulana Azad Medical College, Delhi University. Dr. Miglani has over 12 years experience in the field of Medicine and Clinical research. He is currently the Chief Operating Officer and Scientific Director of CIDP Biotech India where he is responsible for the Medical, Project Management and the Clinical operations. Before Joining CIDP, he was working as the Director of Medical Affairs in CliniRx Research Pvt Ltd. All the medical monitoring activities were carried out under his guidance. He was also responsible for the Pharmacovigilance unit which provides comprehensive drug safety services for Clinical trials and marketed products.

Before CliniRx, Dr. Miglani worked with a Multinational Pharmaceutical company (Ranbaxy) as a Senior Manager in the department of Medical affairs and Clinical Research leading a team of Research Scientists, Medical Monitors and Drug Safety Physicians. He has also worked as a Senior Resident in Cardiology and Medicine Department in some of the prestigious hospitals of New Delhi before joining the clinical research industry. He is a life time member of Association of Physicians of India and Indian Association of Clinical medicine. In his clinical research career he has been associated with a diversified range of therapeutic areas from Gastroenterology, Dermatology, Psychiatry and Neurology to Respiratory diseases. He has numerous publications in medical journals and books to his credit.